Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Operating Expenses (2016 - 2025)

Medifast (MED) has disclosed Operating Expenses for 16 consecutive years, with $59.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses fell 31.5% year-over-year to $59.9 million, compared with a TTM value of $289.4 million through Dec 2025, down 34.49%, and an annual FY2025 reading of $289.4 million, down 34.49% over the prior year.
  • Operating Expenses was $59.9 million for Q4 2025 at Medifast, down from $66.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $272.7 million in Q2 2022 and bottomed at $59.9 million in Q4 2025.
  • Average Operating Expenses over 5 years is $162.4 million, with a median of $161.9 million recorded in 2023.
  • The sharpest move saw Operating Expenses soared 77.04% in 2021, then tumbled 40.82% in 2025.
  • Year by year, Operating Expenses stood at $231.4 million in 2021, then decreased by 13.16% to $201.0 million in 2022, then plummeted by 33.98% to $132.7 million in 2023, then crashed by 34.05% to $87.5 million in 2024, then crashed by 31.5% to $59.9 million in 2025.
  • Business Quant data shows Operating Expenses for MED at $59.9 million in Q4 2025, $66.2 million in Q3 2025, and $77.7 million in Q2 2025.